ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
96 906,36
-0,31%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ASLAN Pharmaceuticals Ltd (ASLN)

  7. ASLAN Pharmaceuticals Ltd (ASLN) Actualités

ASLN

ASLAN Pharmaceuticals (ASLN)

ASLAN Pharmaceuticals Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ASLN
DateHeureSourceTitreSymboleSociété
17/07/202413h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
17/07/202413h25GlobeNewswire Inc.ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary LiquidationNASDAQ:ASLNASLAN Pharmaceuticals Ltd
12/06/202422h32Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202422h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/08/202313h33Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/07/202314h09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/04/202313h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202323h27Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202322h28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/03/202312h33Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
20/03/202322h21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202314h31Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202322h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/11/202221h08Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
31/10/202211h15TipRanksH.C. Wainwright Sticks to Their Buy Rating for Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/09/202212h15TipRanksH.C. Wainwright Remains a Buy on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/09/202222h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/08/202212h25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
23/05/202212h26TipRanksAslan Pharmaceuticals (ASLN) Receives a Buy from H.C. WainwrightNASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/03/202212h26TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/03/202212h54Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/08/202113h46Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/05/202113h30GlobeNewswire Inc.ASLAN Pharmaceuticals to Participate In Fireside Chat at Jefferies Virtual Healthcare ConferenceNASDAQ:ASLNASLAN Pharmaceuticals Ltd
11/05/202113h30GlobeNewswire Inc.ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/05/202111h22GlobeNewswire Inc.ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative DermatologyNASDAQ:ASLNASLAN Pharmaceuticals Ltd
22/04/202113h51GlobeNewswire Inc.ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/04/202112h13Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/03/202121h19Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/03/202112h27GlobeNewswire Inc.ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent DirectorNASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202106h42GlobeNewswire Inc.ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary SharesNASDAQ:ASLNASLAN Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:ASLN

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
NASDAQ
AMZN
Amazon.com
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
SPI
SP500
S&P 500
EU
RNO
Renault
EU
ML
Michelin
EU
MC
Lvmh Moet Hennessy Louis...
EU
HO
Thales
NASDAQ
NVDA
NVIDIA
COIN
XRPUSD
Ripple
EU
ORA
Orange
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés